Enzymatica AB (publ) Stock | ENZY.ST | SE0003943620 | A1WZEV

Date	Enzymatica AB (publ) Price
9/10/2024	1.94 undefined
9/9/2024	1.92 undefined
9/6/2024	1.94 undefined
9/5/2024	1.92 undefined
9/4/2024	1.90 undefined
9/3/2024	1.93 undefined
9/2/2024	1.95 undefined
8/30/2024	1.96 undefined
8/29/2024	1.92 undefined
8/28/2024	1.95 undefined
8/27/2024	2.22 undefined
8/26/2024	2.64 undefined
8/23/2024	2.58 undefined
8/22/2024	2.58 undefined
8/21/2024	2.58 undefined
8/20/2024	2.58 undefined
8/19/2024	2.24 undefined
8/16/2024	2.24 undefined
8/15/2024	1.97 undefined
8/14/2024	1.98 undefined
8/13/2024	1.98 undefined

Date	Enzymatica AB (publ) Revenue	Enzymatica AB (publ) EBIT	Enzymatica AB (publ) Net Income
2026e	197.88 M undefined	-1.53 M undefined	-69.33 M undefined
2025e	118.32 M undefined	-30.6 M undefined	-71.8 M undefined
2024e	58.65 M undefined	-55.59 M undefined	-79.23 M undefined
2023	50.9 M undefined	-48.06 M undefined	-49.73 M undefined
2022	48.95 M undefined	-68.22 M undefined	-68.66 M undefined
2021	57.24 M undefined	-45.25 M undefined	-45.39 M undefined
2020	111.25 M undefined	-12.06 M undefined	-13.22 M undefined
2019	61.31 M undefined	-41.66 M undefined	-40.98 M undefined
2018	52.56 M undefined	-40.58 M undefined	-42.58 M undefined
2017	59.45 M undefined	-30.21 M undefined	-31.45 M undefined
2016	36.48 M undefined	-46.18 M undefined	-45.01 M undefined
2015	27.91 M undefined	-40.52 M undefined	-40.83 M undefined
2014	19.06 M undefined	-32.67 M undefined	-32.39 M undefined
2013	10.49 M undefined	-16.21 M undefined	-16.21 M undefined
2012	900,000 undefined	-7.67 M undefined	-7.57 M undefined
2011	580,000 undefined	-4.92 M undefined	-4.99 M undefined
2010	340,000 undefined	-1.42 M undefined	-1.55 M undefined
2009	0 undefined	-70,000 undefined	-190,000 undefined
2008	0 undefined	-260,000 undefined	-780,000 undefined
2007	0 undefined	0 undefined	-50,000 undefined

	Revenue	EBIT	Net Income
2007	0 SEK	0 SEK	-50,000 SEK
2008	0 SEK	-260,000 SEK	-780,000 SEK
2009	0 SEK	-70,000 SEK	-190,000 SEK
2010	340,000 SEK	-1.42 M SEK	-1.55 M SEK
2011	580,000 SEK	-4.92 M SEK	-4.99 M SEK
2012	900,000 SEK	-7.67 M SEK	-7.57 M SEK
2013	10.49 M SEK	-16.21 M SEK	-16.21 M SEK
2014	19.06 M SEK	-32.67 M SEK	-32.39 M SEK
2015	27.91 M SEK	-40.52 M SEK	-40.83 M SEK
2016	36.48 M SEK	-46.18 M SEK	-45.01 M SEK
2017	59.45 M SEK	-30.21 M SEK	-31.45 M SEK
2018	52.56 M SEK	-40.58 M SEK	-42.58 M SEK
2019	61.31 M SEK	-41.66 M SEK	-40.98 M SEK
2020	111.25 M SEK	-12.06 M SEK	-13.22 M SEK
2021	57.24 M SEK	-45.25 M SEK	-45.39 M SEK
2022	48.95 M SEK	-68.22 M SEK	-68.66 M SEK
2023	50.9 M SEK	-48.06 M SEK	-49.73 M SEK
2024e	58.65 M SEK	-55.59 M SEK	-79.23 M SEK
2025e	118.32 M SEK	-30.6 M SEK	-71.8 M SEK
2026e	197.88 M SEK	-1.53 M SEK	-69.33 M SEK

2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e
0	0	0	0	0	0	10	19	27	36	59	52	61	111	57	48	50	58	118	197
-	-	-	-	-	-	-	90.00	42.11	33.33	63.89	-11.86	17.31	81.97	-48.65	-15.79	4.17	16.00	103.45	66.95
-	-	-	-	-	-	-70.00	73.68	70.37	61.11	61.02	69.23	72.13	67.57	57.89	58.33	62.00	-	-	-
0	0	0	0	-2	-3	-7	14	19	22	36	36	44	75	33	28	31	0	0	0
0	0	0	-1	-4	-7	-16	-32	-40	-46	-30	-40	-41	-12	-45	-68	-48	-55	-30	-1
-	-	-	-	-	-	-160.00	-168.42	-148.15	-127.78	-50.85	-76.92	-67.21	-10.81	-78.95	-141.67	-96.00	-94.83	-25.42	-0.51
0	0	0	-1	-4	-7	-16	-32	-40	-45	-31	-42	-40	-13	-45	-68	-49	-79	-71	-69
-	-	-	-	300.00	75.00	128.57	100.00	25.00	12.50	-31.11	35.48	-4.76	-67.50	246.15	51.11	-27.94	61.22	-10.13	-2.82
0	0	0	14.89	13.34	19.08	21.23	25.94	28.28	66.62	93.41	95.25	142.88	142.88	146.68	154.3	164.26	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

0	0	0	0	1.9	9.7	4.2	37.92	8.07	35.59	10.93	70.3	29.32	24.02	31.62	50.69	8.37
0.1	0	0	0.1	0	0.4	4.7	7.6	9.5	9.51	13.51	10.44	15.29	32.78	16.32	14.23	11.34
0	0	0	4.6	0.3	0.2	1.2	0.13	0.28	3.46	4.25	1.42	1.59	2.98	2.51	2.29	2.15
0	0.1	0.2	1.7	1.5	1.8	5.7	11.89	11.41	6.99	2.69	5.55	7	10.46	12.44	11.51	11.5
0	0	0	0	0.1	0.1	1.9	3.05	0.55	0.8	1.03	2.3	1.47	1.25	1.89	6.13	5.43
0.1	0.1	0.2	6.4	3.8	12.2	17.7	60.59	29.8	56.35	32.41	90.02	54.67	71.49	64.78	84.85	38.78
0	0	0	0	0	0	0.2	0.3	0.28	4.38	4.87	4.54	6.78	10.26	15.16	16.4	16.48
0.1	0.1	0.1	0.1	0	0	0	0	0	0.02	0.02	0	0	0	0	0	2.32
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8.42	0
0.7	0.7	0.9	0.8	0.7	3.8	8	11.28	13.78	36.38	31.63	26.18	20.88	15.37	11.78	7.64	5.12
0	0	0	0	0	0	0	0	0	63.21	63.21	63.21	63.21	63.21	63.21	63.21	63.21
0	0	0	0	0	0	0	0	0	2.31	1.68	1.24	2.17	1.71	2.12	2.32	2.32
0.8	0.8	1	0.9	0.7	3.8	8.2	11.58	14.05	106.29	101.41	95.16	93.04	90.54	92.26	97.98	89.45
0.9	0.9	1.2	7.3	4.5	16	25.9	72.17	43.85	162.64	133.82	185.17	147.71	162.03	157.04	182.83	128.23

0	0	0.1	0.5	0.6	0.7	0.8	1	1	3.64	3.64	5.71	5.71	5.71	5.97	6.57	6.57
0	0	0	0	10	28.2	45.8	123.8	123.8	284.86	284.86	374.25	374.1	376.65	438.83	507.2	507.2
0	0	-1	-0.9	-7.3	-14.9	-30.8	-62.37	-102.81	-147.82	-179.02	-220.86	-261.11	-273.6	-318.99	-387.64	-437.37
0.1	-0.7	0	4.8	0	0	0	0	0	1.01	0.87	0.56	0.5	-2.12	-0.85	0.17	0.21
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.1	-0.7	-0.9	4.4	3.3	14	15.8	62.42	21.98	141.69	110.34	159.66	119.2	106.65	124.97	126.29	76.61
0	0	0.1	0.6	0.3	0.6	7.2	6.58	5.98	4.48	6.31	10.22	10.39	13.94	7.61	6.67	7.37
0	0	0.1	0.1	0.5	1.2	3	2.83	3.97	6.37	7.29	8.7	10.59	26.21	20.02	17.96	11.32
0.3	0.3	0	0.4	0.4	0.2	0.2	0.15	5.98	2.36	1.51	0.97	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0.2	0.2	0.1	0	0	0.34	5.94	0	2.38	1.75	3.32	13.78	2.75	1.2	1.22
0.3	0.3	0.4	1.3	1.3	2	10.4	9.89	21.87	13.2	17.48	21.64	24.3	53.93	30.39	25.82	19.91
0	0	1.2	1.2	0.1	0	0	0	0	7.4	0	3.03	3.41	2.06	1.12	21.12	16.86
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.6	1.5	0.5	0.5	0	0	0	0	0	-0	5.65	0.84	0.8	-0.61	0.56	1.18	12.53
0.6	1.5	1.7	1.7	0.1	0	0	0	0	7.4	5.65	3.87	4.21	1.45	1.68	22.3	29.39
0.9	1.8	2.1	3	1.4	2	10.4	9.89	21.87	20.6	23.12	25.51	28.51	55.38	32.07	48.12	49.3
1	1.1	1.2	7.4	4.7	16	26.2	72.32	43.85	162.29	133.47	185.17	147.71	162.03	157.04	174.41	125.91

2008	2009	2010	null	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
0	0	0	0	-4	-7	-16	-32	-40	-46	-30	-40	-41	-12	-45	-68	-48
0	0	0	0	0	0	0	0	0	3	5	6	7	7	6	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	-5	-5	0	0	-2	-9	2	3	2	6	-3	-4	4	-4	1
0	0	0	0	0	0	0	1	0	0	0	0	0	0	-1	7	6
0	0	0	0	0	0	0	0	0	0	0	1,000	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	-5	-5	-4	-7	-18	-40	-37	-38	-22	-28	-37	-10	-35	-65	-40
0	0	0	0	0	0	0	0	0	-6	-1	0	0	-4	-6	-3	0
0	0	0	0	0	-3	-4	-3	-3	-18	-1	0	0	-4	-6	-3	0
0	0	0	0	0	-3	-4	-4	-3	-12	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	-1	-1	-1	0	0	0	10	-6	0	-2	-2	7	-12	19	-1
0	0	4	4	7	19	18	83	0	100	0	98	0	2	66	74	0
0	0	5	5	7	18	17	78	10	84	0	88	-2	10	49	88	-1
0	0	2	2	0	-1	-1	-1	0	-8	0	-7	0	0	-4	-5	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	1	7	-5	33	-29	27	-24	59	-40	-5	7	19	-42
-0.77	-0.21	-5.78	0	-4.89	-7.25	-18.65	-40.83	-37.74	-44.7	-23.81	-29.31	-38.44	-15.49	-42	-69.16	-41.02
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Enzymatica AB (publ) Gross margin	Enzymatica AB (publ) Profit margin	Enzymatica AB (publ) EBIT margin	Enzymatica AB (publ) Profit margin
2026e	62.59 %	-0.77 %	-35.03 %
2025e	62.59 %	-25.86 %	-60.68 %
2024e	62.59 %	-94.78 %	-135.09 %
2023	62.59 %	-94.42 %	-97.69 %
2022	58.13 %	-139.37 %	-140.27 %
2021	58.26 %	-79.04 %	-79.3 %
2020	68.28 %	-10.84 %	-11.88 %
2019	73.23 %	-67.95 %	-66.84 %
2018	70.02 %	-77.21 %	-81.01 %
2017	61.11 %	-50.82 %	-52.9 %
2016	60.93 %	-126.57 %	-123.36 %
2015	69.6 %	-145.16 %	-146.28 %
2014	74.33 %	-171.36 %	-169.93 %
2013	-70.07 %	-154.53 %	-154.53 %
2012	-342.22 %	-852.22 %	-841.11 %
2011	-450 %	-848.28 %	-860.34 %
2010	-264.71 %	-417.65 %	-455.88 %
2009	62.59 %	0 %	0 %
2008	62.59 %	0 %	0 %
2007	62.59 %	0 %	0 %

	Gross margin	EBIT margin	Profit margin
2007	62.59 %	0 %	0 %
2008	62.59 %	0 %	0 %
2009	62.59 %	0 %	0 %
2010	-264.71 %	-417.65 %	-455.88 %
2011	-450 %	-848.28 %	-860.34 %
2012	-342.22 %	-852.22 %	-841.11 %
2013	-70.07 %	-154.53 %	-154.53 %
2014	74.33 %	-171.36 %	-169.93 %
2015	69.6 %	-145.16 %	-146.28 %
2016	60.93 %	-126.57 %	-123.36 %
2017	61.11 %	-50.82 %	-52.9 %
2018	70.02 %	-77.21 %	-81.01 %
2019	73.23 %	-67.95 %	-66.84 %
2020	68.28 %	-10.84 %	-11.88 %
2021	58.26 %	-79.04 %	-79.3 %
2022	58.13 %	-139.37 %	-140.27 %
2023	62.59 %	-94.42 %	-97.69 %
2024e	62.59 %	-94.78 %	-135.09 %
2025e	62.59 %	-25.86 %	-60.68 %
2026e	62.59 %	-0.77 %	-35.03 %

Date	Enzymatica AB (publ) Sales per Share	Enzymatica AB (publ) EBIT per share	Enzymatica AB (publ) Earnings per Share
2026e	0.82 undefined	0 undefined	-0.29 undefined
2025e	0.49 undefined	0 undefined	-0.3 undefined
2024e	0.24 undefined	0 undefined	-0.33 undefined
2023	0.31 undefined	-0.29 undefined	-0.3 undefined
2022	0.32 undefined	-0.44 undefined	-0.44 undefined
2021	0.39 undefined	-0.31 undefined	-0.31 undefined
2020	0.78 undefined	-0.08 undefined	-0.09 undefined
2019	0.43 undefined	-0.29 undefined	-0.29 undefined
2018	0.55 undefined	-0.43 undefined	-0.45 undefined
2017	0.64 undefined	-0.32 undefined	-0.34 undefined
2016	0.55 undefined	-0.69 undefined	-0.68 undefined
2015	0.99 undefined	-1.43 undefined	-1.44 undefined
2014	0.73 undefined	-1.26 undefined	-1.25 undefined
2013	0.49 undefined	-0.76 undefined	-0.76 undefined
2012	0.05 undefined	-0.4 undefined	-0.4 undefined
2011	0.04 undefined	-0.37 undefined	-0.37 undefined
2010	0.02 undefined	-0.1 undefined	-0.1 undefined
2009	0 undefined	0 undefined	0 undefined
2008	0 undefined	0 undefined	0 undefined
2007	0 undefined	0 undefined	0 undefined

	Sales per Share	EBIT per share	Earnings per Share
2007	0 SEK	0 SEK	0 SEK
2008	0 SEK	0 SEK	0 SEK
2009	0 SEK	0 SEK	0 SEK
2010	0.02 SEK	-0.1 SEK	-0.1 SEK
2011	0.04 SEK	-0.37 SEK	-0.37 SEK
2012	0.05 SEK	-0.4 SEK	-0.4 SEK
2013	0.49 SEK	-0.76 SEK	-0.76 SEK
2014	0.73 SEK	-1.26 SEK	-1.25 SEK
2015	0.99 SEK	-1.43 SEK	-1.44 SEK
2016	0.55 SEK	-0.69 SEK	-0.68 SEK
2017	0.64 SEK	-0.32 SEK	-0.34 SEK
2018	0.55 SEK	-0.43 SEK	-0.45 SEK
2019	0.43 SEK	-0.29 SEK	-0.29 SEK
2020	0.78 SEK	-0.08 SEK	-0.09 SEK
2021	0.39 SEK	-0.31 SEK	-0.31 SEK
2022	0.32 SEK	-0.44 SEK	-0.44 SEK
2023	0.31 SEK	-0.29 SEK	-0.3 SEK
2024e	0.24 SEK	0 SEK	-0.33 SEK
2025e	0.49 SEK	0 SEK	-0.3 SEK
2026e	0.82 SEK	0 SEK	-0.29 SEK

	Number of stocks
2007	0 Aktien
2008	0 Aktien
2009	0 Aktien
2010	14.89 M Aktien
2011	13.34 M Aktien
2012	19.08 M Aktien
2013	21.23 M Aktien
2014	25.94 M Aktien
2015	28.28 M Aktien
2016	66.62 M Aktien
2017	93.41 M Aktien
2018	95.25 M Aktien
2019	142.88 M Aktien
2020	142.88 M Aktien
2021	146.68 M Aktien
2022	154.3 M Aktien
2023	164.26 M Aktien
2024e	164.26 M Aktien
2025e	164.26 M Aktien
2026e	164.26 M Aktien

Date	EPS Estimate	EPS Actual	Quarterly report
6/30/2022	0	-0.1 (0 %)	2022 Q2
12/31/2020	0.13	0 (-100 %)	2020 Q4
9/30/2020	-0.04	-0.01 (75.49 %)	2020 Q3
6/30/2020	0	-0.08 (0 %)	2020 Q2
3/31/2020	0	-0.01 (0 %)	2020 Q1
12/31/2019	-0.06	-0.04 (34.66 %)	2019 Q4
6/30/2019	-0.08	-0.11 (-34.75 %)	2019 Q2
3/31/2019	-0.08	-0.09 (-10.26 %)	2019 Q1
6/30/2018	-0.1	-0.17 (-66.75 %)	2018 Q2
3/31/2018	-0.11	-0.11 (1.99 %)	2018 Q1
12/31/2017	-0.16	-0.06 (63.24 %)	2017 Q4
9/30/2017	-0.09	-0.04 (56.42 %)	2017 Q3
6/30/2017	-0.12	-0.12 (1.96 %)	2017 Q2

%	Name	Stocks	Change	Date
9.18064 %	Roos (Hakan)	22,284,620	0	12/31/2023
7.82881 %	Algkvist (Bjorn)	19,003,261	0	12/31/2023
2.69670 %	Palmason (Gudmundur)	6,545,837	0	12/31/2023
2.13841 %	Gudmundsdottir (Agusta)	5,190,679	0	12/31/2023
14.99503 %	Andersson (Mats K.)	36,398,195	0	12/31/2023
1.96900 %	Nordnet Pensionsforsakring AB	4,779,450	137,425	12/31/2023
1.72204 %	AB Possessor	4,180,000	0	12/31/2023
1.44514 %	Baron (Bengt)	3,507,859	0	12/31/2023
1.36730 %	Swedbank Försäkring AB	3,318,910	4,000	12/31/2023
1.27780 %	Stendahl (Tom)	3,101,658	0	12/31/2023
0.06733 %	Willberg (Helene)	163,423	163,423	12/31/2022
0.01771 %	Nicolin (Louise)	43,000	43,000	12/31/2022
0.00318 %	Evli Fund Management Company Ltd.	7,712	0	2/29/2024
0.00318 %	Alfred Berg Kapitalforvaltning AS	7,712	7,712	11/30/2023
0 %	State Street Global Advisors (US)	0	-187,156	9/30/2022

Name	Relationship	Two-week correlation	One-month correlation	Three-Month Correlation	Six-Month Correlation	One Year Correlation	Two-Year Correlation
Amazon.com	SupplierCustomer	0,48	0,71	0,54	0,70	0,68	-0,07
Walgreens Boots Alliance	SupplierCustomer	0,03	0,34	0,34	-0,11	0,15	-0,65
Shanghai Pharm Hldg H	SupplierCustomer	-	-0,55	0,45	-0,01	0,48	-0,41
EBOS Group	SupplierCustomer	-0,31	0,69	0,05	-0,30	-0,80	-0,87
Sanofi	SupplierCustomer	-0,40	0,19	-0,02	-0,48	-0,72	-0,67

What values and corporate philosophy does Enzymatica AB (publ) represent?

Enzymatica AB (publ) is a company that embodies strong values and a clear corporate philosophy. The company focuses on developing and offering medical devices and healthcare products based on natural substances and enzymes. Enzymatica AB (publ) values innovation, research, and sustainability, striving to enhance human health with safe, effective, and environmentally friendly solutions. The company's commitment to excellence and quality is reflected in their products, which are designed to provide effective and gentle relief for various health conditions. Enzymatica AB (publ) is dedicated to improving the overall well-being of individuals and promoting a healthier future through their natural and scientifically-validated approach.

In which countries and regions is Enzymatica AB (publ) primarily present?

Enzymatica AB (publ) is primarily present in several countries and regions globally. The company has a strong presence in Sweden, its home country, where it is headquartered. Additionally, Enzymatica operates in other European countries including Norway, Denmark, Finland, and the United Kingdom. The company has expanded its business and distribution networks to reach markets in the Middle East, Asia, and Africa as well. With a focus on improving people's health, Enzymatica continues to explore potential opportunities for growth and expansion into new regions worldwide.

What significant milestones has the company Enzymatica AB (publ) achieved?

Some significant milestones achieved by Enzymatica AB (publ) include the launch of their flagship product, ColdZyme®, a cold spray that targets the cause of the common cold. The company has successfully expanded its geographical reach, securing partnerships and distribution agreements in several countries. Enzymatica has also received regulatory approvals and certifications, such as CE marking, allowing them to market their products across Europe. Additionally, the company has conducted successful clinical trials, highlighting the efficacy and safety of their products. Enzymatica AB (publ) continues to innovate and collaborate in the field of healthcare, aiming to improve the lives of individuals through their effective products.

What is the history and background of the company Enzymatica AB (publ)?

Enzymatica AB (publ) is a renowned Swedish biotech company specializing in developing and marketing medical devices. Established in 2007, Enzymatica has achieved significant milestones throughout its history. The company's primary focus is on creating innovative solutions for infectious respiratory diseases, such as colds and flu. Enzymatica is widely recognized for its flagship product ColdZyme®, a mouth spray designed to reduce the risk of catching a cold. With a strong commitment to research and development, Enzymatica continues to expand its product portfolio and presence in global markets. The company's dedication to providing effective and safe healthcare products has earned it a reputable position in the industry.

Who are the main competitors of Enzymatica AB (publ) in the market?

The main competitors of Enzymatica AB (publ) in the market include pharmaceutical companies such as GlaxoSmithKline, Reckitt Benckiser, and Johnson & Johnson. These companies, like Enzymatica AB (publ), are involved in the development and commercialization of healthcare products, including nasal sprays and oral care solutions. They operate in the same industry and compete for market share with Enzymatica AB (publ) by offering similar products and solutions to consumers worldwide.

In which industries is Enzymatica AB (publ) primarily active?

Enzymatica AB (publ) primarily operates in the pharmaceutical and healthcare industries.

What is the business model of Enzymatica AB (publ)?

Enzymatica AB (publ) operates with a business model focused on developing, producing, and marketizing innovative medical devices and healthcare products. The company specializes in enzymatic technology and develops products for ear care, oral care, and wound care. Enzymatica AB (publ) aims to address unmet medical needs through extensive research and development. With a strong emphasis on quality and scientific expertise, the company strives to bring effective and safe solutions to the healthcare market. Enzymatica AB (publ) continues to expand its product portfolio and enhance its presence in the global healthcare industry, creating value for both customers and shareholders.

What is the P/E ratio of Enzymatica AB (publ) 2024?

The Enzymatica AB (publ) P/E ratio is -4.02.

What is the P/S ratio of Enzymatica AB (publ) 2024?

The Enzymatica AB (publ) P/S ratio is 5.43.

What is the AlleAktien quality score of Enzymatica AB (publ)?

The AlleAktien quality score for Enzymatica AB (publ) is 6/10.

What is the revenue of Enzymatica AB (publ) 2024?

The expected Enzymatica AB (publ) revenue is 58.65 M SEK.

How high is the profit of Enzymatica AB (publ) 2024?

The expected Enzymatica AB (publ) profit is -79.23 M SEK.

What is the business model of Enzymatica AB (publ)

Enzymatica AB (publ) is a Swedish company specializing in the development, production, and marketing of medical products for the treatment of respiratory infections and other diseases. The company's business model is based on a combination of high-quality products, innovative technologies, and strong marketing strategies. It has three divisions: Enzymatica medical, Enzymatica consumer, and Enzymatica research. Each division is specialized in a specific market and offers a range of products tailored to the needs of its respective target audience. Enzymatica medical develops medical products for the treatment of respiratory infections, sore throats, and other diseases. Enzymatica consumer manufactures products for health promotion and disease prevention. Enzymatica research focuses on the development of new products and technologies. The company has a strong marketing strategy, utilizing social media platforms, print and online advertising, and participation in relevant conferences and trade shows. Overall, Enzymatica AB (publ) offers innovative products and technologies for the treatment and prevention of respiratory and other diseases and continues to expand its presence in pharmacies and stores.

What is the Enzymatica AB (publ) dividend?

Enzymatica AB (publ) pays a dividend of 0 SEK distributed over payouts per year.

How often does Enzymatica AB (publ) pay dividends?

The dividend cannot currently be calculated for Enzymatica AB (publ) or the company does not pay out a dividend.

What is the Enzymatica AB (publ) ISIN?

The ISIN of Enzymatica AB (publ) is SE0003943620.

What is the Enzymatica AB (publ) WKN?

The WKN of Enzymatica AB (publ) is A1WZEV.

What is the Enzymatica AB (publ) ticker?

The ticker of Enzymatica AB (publ) is ENZY.ST.

How much dividend does Enzymatica AB (publ) pay?

Over the past 12 months, Enzymatica AB (publ) paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Enzymatica AB (publ) is expected to pay a dividend of 0 SEK.

What is the dividend yield of Enzymatica AB (publ)?

The current dividend yield of Enzymatica AB (publ) is .

When does Enzymatica AB (publ) pay dividends?

Enzymatica AB (publ) pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Enzymatica AB (publ)?

Enzymatica AB (publ) paid dividends every year for the past 0 years.

What is the dividend of Enzymatica AB (publ)?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Enzymatica AB (publ) located?

Enzymatica AB (publ) is assigned to the 'Health' sector.

Wann musste ich die Aktien von Enzymatica AB (publ) kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Enzymatica AB (publ) from 9/11/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 9/11/2024.

When did Enzymatica AB (publ) pay the last dividend?

The last dividend was paid out on 9/11/2024.

What was the dividend of Enzymatica AB (publ) in the year 2023?

In the year 2023, Enzymatica AB (publ) distributed 0 SEK as dividends.

In which currency does Enzymatica AB (publ) pay out the dividend?

The dividends of Enzymatica AB (publ) are distributed in SEK.

Scope 1 - Direct Emissions	—
Scope 2 - Indirect emissions from purchased energy	—
Scope 3 - Indirect emissions within the value chain	—
Total CO₂ emissions	—
CO₂ reduction strategy	✅
Coal energy	❌
Nuclear power	❌
Animal experiments	❌
Fur & Leather	—
Pesticides	—
Palm Oil	—
Tobacco	❌
Genetically modified organisms	❌
Climate concept	—
Sustainable forestry	—
Recycling regulations	❌
Environmentally friendly packaging	❌
Hazardous substances	❌
Fuel consumption and efficiency	❌
Water consumption and efficiency	❌

Percentage of female employees	—
Percentage of women in management	—
Percentage of Asian employees	—
Share of Asian management	—
Percentage of Hispanic/Latino employees	—
Hispano/Latino Management share	—
Percentage of Black employees	—
Black Management Share	—
Percentage of white employees	—
White Management Share	—
Adult content	❌
Alcohol	❌
Weapons	—
Firearms	❌
Gambling	❌
Military contracts	❌
Human rights concept	✅
Privacy concept	—
Occupational health and safety	✅
Catholic	✅

Environmental reporting	❌
Stakeholder Engagement	❌
Call Back Policies	❌
Antitrust law	❌

Stock Exchange	Enzymatica AB (publ) Ticker
FRANKFURT	EN9.F
MUNICH	EN9.MU
STOCKHOLM	ENZY.ST
STOCKHOLM	ENZY.ST

Enzymatica AB (publ) Ticker	Enzymatica AB (publ) FIGI
ENZY:SF	BBG001Y25Z66
ENZYSEK:EO	BBG0058M9WN6
ENZYSEK:XH	BBG0058M9WR2
ENZYSEK:XF	BBG0058M9WT0
ENZYSEK:XE	BBG0058M9WW6
ENZYSEK:XJ	BBG0058M9WX5
ENZYSEK:XL	BBG0058M9WY4
ENZYSEK:XG	BBG0058M9WZ3
ENZYSEK:XO	BBG0058M9X09
ENZYSEK:XS	BBG0058M9X45
ENZYSEK:XA	BBG0058M9X54
ENZYSEK:E1	BBG0058M9X63
ENZYSEK:XT	BBG0058M9X72
ENZYSEK:XW	BBG0058M9X81
ENZYSEK:XU	BBG0058M9X90
ENZYSEK:EU	BBG0058M9XD5
ENZYSEK:XV	BBG005925P76
ENZYS:PO	BBG00JL70MS0
ENZYS:B3	BBG00JLWT5G4
ENZYS:L3	BBG00JLXDBL0
ENZYSEK:XX	BBG00JN839F6
EN9:GR	BBG00MNLXH41
EN9:GF	BBG00MNLXH50
EN9:GS	BBG00MNLXH87
EN9:GM	BBG00MNLXH96
EN9:GB	BBG00MNLXHB3
ENZYEUR:XS	BBG00W7G9WY9
ENZYEUR:X2	BBG00W7G9WZ8
ENZYEUR:XH	BBG00W7G9X13
ENZYEUR:XF	BBG00W7G9X31
ENZYEUR:XE	BBG00W7G9X68
ENZYEUR:XJ	BBG00W7G9X77
ENZYEUR:XL	BBG00W7G9X86
ENZYEUR:XG	BBG00W7G9X95
ENZYEUR:XO	BBG00W7G9XB2
ENZYEUR:XP	BBG00W7G9XD0
ENZYEUR:XA	BBG00W7G9XG7
ENZYEUR:E1	BBG00W7G9XH6
ENZYEUR:XT	BBG00W7G9XJ4
ENZYEUR:XW	BBG00W7G9XK2
ENZYEUR:XU	BBG00W7G9XL1
ENZYEUR:XV	BBG00W7G9XN9
ENZYEUR:XM	BBG00W7G9XP7
ENZYEUR:XQ	BBG00W7G9XQ6
ENZYEUR:XX	BBG00W7G9XR5
ENZYEUR:XZ	BBG00W7G9XS4
ENZYEUR:X1	BBG00W7G9XV0
ENZYEUR:EU	BBG00W7G9Y20
EN9:GZ	BBG00WC6S6F2
ENZYEUR:EP	BBG00WC6VP84
ENZYEUR:EZ	BBG00WC6VPB0
ENZYS:L1	BBG00Y90WY78

Own the gold standard ✨ in financial data & analytics fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Price

Price

TickerENZY.ST

ISINSE0003943620

WKNA1WZEV

Enzymatica AB (publ) stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

Enzymatica AB (publ) Stock Price History

Enzymatica AB (publ) Revenue, EBIT, Net Income SE0003943620 · A1WZEV

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Yearly Analysis and Comparisons

Utilizing Expectations for Investment

Investment Insights

Enzymatica AB (publ) Revenue, EBIT and net profit per share

Enzymatica AB (publ) Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

Enzymatica AB (publ) stock margins SE0003943620 · A1WZEV

Margin

Understanding Gross Margin

EBIT Margin Analysis

Revenue Margin Insights

Interpreting Expectations

Comparative Analysis

Enzymatica AB (publ) Margin History

Enzymatica AB (publ) Stock Sales Revenue, EBIT, Earnings per Share SE0003943620 · A1WZEV

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Enzymatica AB (publ) Revenue, EBIT and net profit per share

Enzymatica AB (publ) business model

Enzymatica AB (publ) SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

Enzymatica AB (publ) Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

Enzymatica AB (publ) historical P/E ratio, EBIT, and P/S ratio.

Enzymatica AB (publ) shares outstanding SE0003943620 · A1WZEV

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Enzymatica AB (publ) Earnings Estimates

Enzymatica AB (publ) latest earnings and earnings surprises

Eulerpool ESG Scorecard© for the Enzymatica AB (publ) stock

Eulerpool World ESG Rating (EESG©)

41/ 100

🌱 Environment

👫 Social

🏛️ Governance

Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Ticker
ENZY.ST

ISIN
SE0003943620

WKN
A1WZEV